BioScrip (BIOS) Tops Q3 EPS Views

BioScrip (NASDAQ: BIOS) reported Q3 EPS of $0.42, $0.40 better than the analyst estimate of $0.02. Revenue for the quarter came in at $244 million versus the consensus estimate of $240.08 million.

For earnings history and earnings-related data on BioScrip (BIOS) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• STAAR Surgical (STAA) PT Lowered to $28 at Stifel After Net-Positive Earnings Call
• L3Harris names Sam Mehta CEO after Kubasik exits over conduct issues